Empatab 10 mg (Tablet)
Unit Price: ৳ 25.00 (3 x 10: ৳ 750.00)
Strip Price: ৳ 250.00
Medicine Details
| Category | Details |
|---|---|
| Generic | Empagliflozin |
| Company | Incepta pharmaceuticals ltd |
| Also available as |
Indications
- Adjunct to diet and exercise for type 2 diabetes mellitus
- Reduction of cardiovascular death risk in type 2 diabetes mellitus with established cardiovascular disease
Pharmacology
Sodium glucose co-transporter-2 (SGLT-2) inhibitor
Dosage & Administration
Recommended dose of 10 mg once daily, can be increased to 25 mg once daily
Interaction
- Increased urine volume with diuretics
- Increased risk of hypoglycemia with insulin
- Urinary glucose test interference
- Interference with 1,5-anhydroglucitol (1,5-AG) assay
Contraindications
- History of serious hypersensitivity reaction
- Severe renal impairment
- End-stage renal disease
- Dialysis
Side Effects
- Urinary tract infections
- Female genital mycotic infections
- Dehydration
- Hypotension
- Weakness
- Dizziness
- Increased thirstiness
Pregnancy & Lactation
- Limited studies in pregnant women
- Use during pregnancy if benefit justifies risk
- Not recommended during breastfeeding
Precautions & Warnings
- Assessment of renal function recommended
- Not to be initiated in patients with eGFR < 45 ml/min/1.73 m2
- No dose adjustment for eGFR ≥ 45 ml/min/1.73 m2
Overdose Effects
Usual supportive measures recommended in case of overdose
Therapeutic Class
Sodium-glucose Cotransporter-2 (SGLT2) Inhibitors
Storage Conditions
Keep in a cool & dry place (below 30°C), protected from light & moisture, keep out of the reach of children
Chemical Structure
- Molecular Formula: C23H27ClO7
- Chemical Structure Image Link: https://medex.com.bd/storage/res/g-res-1275-empagliflozin-chemical-structure-Z3X0mrA6UvgM682Jgp8K.svg
Common Questions about Empatab 10 mg Tablet
- Used to improve glycemic control in adults
- May be unsafe to use during pregnancy
- Probably unsafe to use during breastfeeding
- Should be used cautiously in patients with an underlying kidney disease
- No dose adjustment needed for patients with mild to moderate liver disease
- Quick tips for usage